oleoyl ethanolamide | CAS:111-58-0

We serve oleoyl ethanolamide CAS:111-58-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
oleoyl ethanolamide

Chemical Name: oleoyl ethanolamide
Synonyms:N-(2-Hydroxyethyl)oleamide
9Z-octadecenoylethanolamide
N-(Hydroxyethyl)oleamide N-(cis-9-Octadecenoyl)ethanolamine OEA oleoylethanolamide
N-Oleoylethanolamine
 
CAS.NO: 111-58-0
Molecular Formula: C20H39NO2
Molecular Weight: 325.52900
 
Physical and Chemical Properties:
Density: 0.915 g / cm3
Boiling point: 496.4ºC at 760 mmHg
Melting point: 50-60ºC
Flash point: 254ºC
Refractive index: 1.473
 
Specification:
Appearance:White to off-white solid
Purity:≥98%
 
Packing: 1KG/ bag,25KG/DRUM or customized
Storage:-20 ° C sealed storage
Application:Oleoylethanolamide is a high-affinity endogenous PPAR-α agonist that plays an important role in the treatment of obesity and arteriosclerosis.



Contact us for information like oleoyl ethanolamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-Oleoylethanolamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Oleoylethanolamine Use and application,N-(Hydroxyethyl)oleamide N-(cis-9-Octadecenoyl)ethanolamine OEA oleoylethanolamide technical grade,usp/ep/jp grade.


Related News: You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs.3-Aminophenylacetylene manufacturer You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs.5-bromo-2-fluoro-3-methylpyridine supplier The ban will be in place for up to 14 days, and is aimed at helping contain the spread of the Wuhan coronavirus. So far, there have been no confirmed coronavirus cases in New Zealand or any South Pacific island.2,5-Difluorotoluene vendor Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.When a new strain emerges that has not yet been identified, as is the case with the current outbreak in China, it temporarily becomes known as a novel coronavirus (nCoV).